Budget Range
Min
€1,500
Average
€37,271
Max
€136,063
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (34)
P
Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
HORIZON.2.1101213916
€136,063
P
Impact of cell shapes on cell behaviour and fate
ERC (European Research Council)101071470
€108,348
P
Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
Health101096362
€106,073
P
Genome control by DNA-looping motors: from folding to function
HORIZON.1.1101224824
€100,000
P
A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT
Health101136379
€99,993
P
COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE
Health101103746
€99,841
P
Novel health care strategies for melanoma in children, adolescents and young adults
Health101096667
€80,132
P
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
Health101137028
€72,324
P
Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
Health101080823
€69,980
P
Improving quality of life of advanced pancreatic cancer patients through an AI-guided multimodal intervention, combining pain and cachexia management, nutrition, and physical activity
Health101057821
€59,973
C
Assessing the role of intratumoral microbiota in therapy responses using patient-derived tumor-on-chip
HORIZON.2.1101136464
€52,490
P
From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
MSCA (Marie Skłodowska-Curie)101081481
€37,632
P
Real-Time high-content Super-Resolution Imaging of ES Cell States
HORIZON.3.1101099654
€34,885
P
Deconstructing and Rewiring RNA-RBP regulatory networks
MSCA (Marie Skłodowska-Curie)101073094
€26,038
P
Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancer
European Innovation Council101136703
€25,000
P
HOst-Transposon Interactions in the MAle GErmline
HORIZON.1.1101098236
€24,993
P
Controlling cell lineage integrity to intercept tumor initiation
ERC (European Research Council)101170136
€21,569
P
Quantifying cell dynamics in myelopoiesis during immune responses
ERC (European Research Council)101125069
€20,000
P
The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation
MSCA (Marie Skłodowska-Curie)101182922
€16,560
C
Deciphering stem cell immunity
HORIZON.1.1101075865
€15,000
P
Centre for Excellence in Diagnostic and Advanced Therapeutics based on Extracellular Vesicles
Widening Participation101079264
€14,872
P
Boosting future REsearchers in biomaterials for Advanced healTH solutions
HORIZON.1.2101217314
€13,536
P
Advanced technologies for zeroing in on high-grade gliomas
MSCA (Marie Skłodowska-Curie)101236541
€7,916
C
CrowdControl: Identifying the mechanism underlying intracellular density homeostasis.
MSCA (Marie Skłodowska-Curie)101154995
€3,325
C
Determining the role of tubulin polyglutamylation in the regulation of neuronal functions
MSCA (Marie Skłodowska-Curie)101207124
€2,423
C
Investigating DC migration with large, ingested cargos through confining environments
MSCA (Marie Skłodowska-Curie)101207189
€2,423
C
Unraveling mechanisms of immunotherapy resistance through biomarker profiling in triple-negative breast cancer
MSCA (Marie Skłodowska-Curie)101209205
€2,264
C
Regulation of epithelial-cells renewal by basement membrane protein composition and stiffness during gut homeostasis
MSCA (Marie Skłodowska-Curie)101066253
€2,118
C
Role of astrogliosis in the recurrence of brain tumors after microsurgical resection
MSCA (Marie Skłodowska-Curie)101061921
€2,097
C
Dissecting host-transposon interactions during germline development and their impact on genome integrity
MSCA (Marie Skłodowska-Curie)101147418
€1,959
C
Development and trafficking of type 1 and type 17 mucosal-associated invariant T cells
MSCA (Marie Skłodowska-Curie)101109409
€1,959
C
Force production of myosin 18 and its molecular sociology with myosin 2
MSCA (Marie Skłodowska-Curie)101155280
€1,959
C
Deciphering the interplay between stem cell differentiation and stem cell dynamics in branching morphogenesis
MSCA (Marie Skłodowska-Curie)101146540
€1,959
C
To develop a new targeted therapy for the treatment of naive and PARP inhibitor-resistant BRCA1/2-mutated tumors
HORIZON.1.1101059469
€1,500